J. Revilla

Long‐term Oral Tacrolimus Therapy in Refractory to Infliximab Fistulizing Crohn's Disease.: A Pilot Study

P. Escartín, Y. González-Lama, M. Vera, 2005, Inflammatory bowel diseases.

Impact of the incorporation of a nurse in an inflammatory bowel disease unit

M. Calvo, Y. González-Lama, M. Vera, 2016 .

P0641 : Excellent 5-year survival in caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy and the impact of hepatocellular carcinoma (HCC)

M. Buti, R. Idilman, C. Yurdaydın, 2015 .

Peginterferon alpha‐2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels

J. Calleja, R. Solá, J. García-Samaniego, 2012, Journal of gastroenterology and hepatology.

Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease

Marta Hernández, J. Calleja, J. Revilla, 2017, Journal of gastroenterology and hepatology.

Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysis

M. Buti, X. Forns, J. Calleja, 2015, Liver international : official journal of the International Association for the Study of the Liver.

RISK SCORE FOR HEPATOCELLULAR CARCINOMA IN CAUCASIANS WITH CHRONIC HEPATITIS B UNDER 5-YEAR ENTECAVIR OR TENOFOVIR THERAPY

Ramazan, Ioannis, Galanis, 2015 .

Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.

V. Cuervas-Mons, A. Herreros, J. Revilla, 2003, Transplantation proceedings.

Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.

V. Cuervas-Mons, J. M Moreno, E Rubio, 2003, Transplantation proceedings.